Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vritrans 500mg Injection

Prescription Icon
Prescription Required

Marketer

Vrinda Life

Salt Composition

Tranexamic Acid (500mg)

Overview Vritrans 500mg Injection

Transifib 500mg Injection effectively manages hemorrhage. Its application encompasses procedures such as dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and various surgeries involving the oral cavity, prostate, or bladder. This antifibrinolytic medication functions by inhibiting clot dissolution, thus controlling bleeding. Administration should always be overseen by a qualified medical practitioner. Prior known hypersensitivity to this injection contraindicates its use. Commonly reported adverse effects include local injection site reactions, fatigue, musculoskeletal discomfort, and nasal stuffiness. Disclosure of prior cardiac surgery or existing renal impairment is crucial. This injection is considered safe for use during pregnancy and lactation, and poses no significant risk to individuals with hepatic dysfunction.

Uses of Vritrans 500mg Injection

Managing Hemorrhage

Major Benefits of Vritrans 500mg Injection:

Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.

Common Side effects of Vritrans 500mg Injection:

  • Joint pain
  • Headache
  • Back pain
  • Vomiting
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Muscle cramp
  • Anemia (low number of red blood cells)
  • Lightheadedness

How to use Vritrans 500mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Vritrans 500mg Injection works:

Hemostatic agent Vritrans 500mg Injection inhibits fibrinolysis, thus preventing clot dissolution and managing significant hemorrhage associated with menstruation or post-operative complications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Vritrans 500mg Injection and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the administration of Vritrans 500mg Injection to pregnant individuals is currently lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of the injectable medication Vritrans 500mg while breastfeeding is likely inadvisable. Available human data indicates a potential for the drug's transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Vritrans 500mg Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Vritrans 500mg Injection cautiously; dosage modification may be necessary. A physician's consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

Vritrans 500mg Injection appears to be well-tolerated by individuals with hepatic impairment. Current evidence indicates dose modification for Vritrans 500mg Injection may be unnecessary in such cases. Physician consultation is recommended.

What if you forget to take Vritrans 500mg Injection :

Omit Vritrans 500mg Injection doses should prompt immediate physician consultation.

Facts to Know About Vritrans 500mg Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP

FAQs on Vritrans 500mg Injection

Vritrans 500mg Injection must be administered intravenously, via slow injection only. Intramuscular injection is contraindicated to avoid adverse reactions.
All medications carry potential side effects, though these are less likely when taken as prescribed. The benefits typically outweigh the risks. Rarely, Vritrans 500mg Injection may cause serious, potentially dangerous side effects such as anaphylaxis (rash, breathing difficulties, facial/oral/eye swelling), blood clots, or eye problems. Always consult your doctor before starting this medication and adhere strictly to their instructions.
Vritrans 500mg Injection helps stop bleeding by promoting blood clotting. Rarely, it may increase the risk of deep vein thrombosis (DVT), a blood clot in the leg. Studies suggest other factors may contribute to this risk, which appears higher in women using Vritrans 500mg Injection. Always consult your doctor before use and follow their instructions carefully.
Prolonged Vritrans 500mg Injection treatment may affect your color vision. Regular eye exams are therefore recommended, and any vision changes should be reported to your doctor immediately. They may discontinue the medication and prescribe an alternative if necessary.
Vritrans 500mg Injection enhances blood clotting. While rare, it may cause a blood clot to travel to the lungs (pulmonary embolism), potentially fatally. Although uncommon, pulmonary embolism risk increases with overdose, prolonged immobility, or predisposing conditions. Other factors may also contribute to this increased risk.
Vritrans 500mg Injection may be administered with or without food, accompanied by water. The injection should be given whole; do not crush or chew.
Dosage and treatment length for this medication vary depending on the condition. For heavy menstrual bleeding, a typical course lasts five days. For other conditions, the doctor determines the appropriate duration, which may be shorter or longer than five days.
Vritrans 500mg Injection does not impact fertility. Used to treat heavy menstrual bleeding, it shows no evidence of interfering with ovulation. Consequently, it's not a contraceptive and won't affect pregnancy chances.
Yes, Vritrans 500mg Injection can treat nosebleeds by promoting blood clotting and stopping bleeding. For recurrent nosebleeds, treatment may continue for up to a week.
Vritrans 500mg Injection
56
MRP 65
13% off